Metabolic syndrome is associated with change in subclinical arterial stiffness - A community-based Taichung Community Health Study

BMC Public Health

Volumn 11, Issue , 2011, Pages

  Li, Chia Ing ^a,b,c   Kardia, Sharon Lr ^d   Liu, Chiu Shong ^a,b   Lin, Wen Yuan ^a,b   Lin, Chih Hsueh ^a,b   Lee, Yi Dar ^e,f   Sung, Fung Chang ^c   Li, Tsai Chung ^c,g   Lin, Cheng Chieh ^a,b,g  

^a CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^b CHINA MEDICAL UNIVERSITY   (Taiwan)

^c CHINA MEDICAL UNIVERSITY   (Taiwan)

^d UNIVERSITY OF MICHIGAN   (United States)

^e NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^f BRISTOL MYERS SQUIBB   (United States)

^g ASIA UNIVERSITY   (Taiwan)

Author keywords

arterial stiffness; metabolic syndrome; pulse wave velocity

Indexed keywords

ADULT; AGED; ANKLE BRACHIAL INDEX; ANTHROPOMETRY; ARTERIAL STIFFNESS; ARTICLE; FEMALE; HUMAN; MALE; METABOLIC SYNDROME X; MIDDLE AGED; PHYSIOLOGY; RISK; STATISTICAL MODEL; TAIWAN;

ADULT; AGED; ANKLE BRACHIAL INDEX; ANTHROPOMETRY; FEMALE; HUMANS; LINEAR MODELS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; ODDS RATIO; TAIWAN; VASCULAR STIFFNESS;

EID: 80054054680     PISSN: None     EISSN: 14712458     Source Type: Journal    
DOI: 10.1186/1471-2458-11-808     Document Type: Article

References (41)

1. The metabolic syndrome and 11-year risk of incident cardiovascular disease in the atherosclerosis risk in communities study. McNeill AM, Rosamond WD, Girman CJ, Golden SH, Schmidt MI, East HE, Ballantyne CM, Heiss G, Diabetes Care 2005 28 2 385 390 10.2337/diacare.28.2.385 15677797 (Pubitemid 40170944)
2. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA 2001 285 19 2486 2497 10.1001/jama.285.19.2486 11368702
3. Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. Ford ES, Giles WH, Dietz WH, JAMA 2002 287 3 356 359 10.1001/jama.287.3.356 11790215 (Pubitemid 34251969)
4. Metabolic syndrome in a Taiwanese metropolitan adult population. Lin CC, Liu CS, Lai MM, Li CI, Chen CC, Chang PC, Lin WY, Lee YD, Lin T, Li TC, BMC Public Health 2007 7 239 10.1186/1471-2458-7-239 17850675 (Pubitemid 350046018)
5. Prevalence and characteristics of the metabolic syndrome in the San Antonio Heart and Framingham Offspring Studies. Meigs JB, Wilson PW, Nathan DM, D'Agostino RB, Williams K, Haffner SM, Diabetes 2003 52 8 2160 2167 10.2337/diabetes.52.8.2160 12882936 (Pubitemid 36919812)
6. Prevalence and clinical characteristics of metabolic syndrome in a rural population of South Korea. Kim ES, Han SM, Kim YI, Song KH, Kim MS, Kim WB, Park JY, Lee KU, Diabet Med 2004 21 10 1141 1143 10.1111/j.1464-5491.2004.01398.x 15384963 (Pubitemid 39389228)
7. Characteristics and prevalence of the metabolic syndrome among three ethnic groups in Canada. Liu J, Hanley AJ, Young TK, Harris SB, Zinman B, Int J Obes (Lond) 2006 30 4 669 676 10.1038/sj.ijo.0803179
8. Prevalence and characteristics of metabolic syndrome in 111 Royal Jordanian Air Force pilots. Khazale NS, Haddad F, Aviat Space Environ Med 2007 78 10 968 972 10.3357/ASEM.2097.2007 17955946 (Pubitemid 47511956)
9. Prevalence and Clinical Characteristics of Metabolic Syndrome for At-Risk People in a Rural Community. Oh EG, Bang SY, Hyun SS, Metab Syndr Relat Disord 2008
10. The metabolic syndrome: prevalence and associated risk factor findings in the US population from the Third National Health and Nutrition Examination Survey, 1988-1994. Park YW, Zhu S, Palaniappan L, Heshka S, Carnethon MR, Heymsfield SB, Arch Intern Med 2003 163 4 427 436 10.1001/archinte.163.4.427 12588201 (Pubitemid 36241019)
11. Prevalence and risk factors associated with the metabolic syndrome and dyslipidemia in White, Black, Amerindian and Mixed Hispanics in Zulia State, Venezuela. Florez H, Silva E, Fernandez V, Ryder E, Sulbaran T, Campos G, Calmon G, Clavel E, Castillo-Florez S, Goldberg R, Diabetes Res Clin Pract 2005 69 1 63 77 10.1016/j.diabres.2004.11.018 15955388 (Pubitemid 40813413)
12. Duration of lactation is associated with lower prevalence of the metabolic syndrome in midlife - SWAN, the study of women's health across the nation. Ram KT, Bobby P, Hailpern SM, Lo JC, Schocken M, Skurnick J, Santoro N, Am J Obstet Gynecol 2008 198 3 268 e261 266 18191796
13. The metabolic syndrome as a predictor of incident diabetes mellitus in Mauritius. Cameron AJ, Zimmet PZ, Soderberg S, Alberti KG, Sicree R, Tuomilehto J, Chitson P, Shaw JE, Diabet Med 2007 24 12 1460 1469 10.1111/j.1464-5491.2007. 02288.x 17976203 (Pubitemid 350179441)
14. Metabolic syndrome, its preeminent clusters, incident coronary heart disease and all-cause mortality - results of prospective analysis for the Atherosclerosis Risk in Communities study. Hong Y, Jin X, Mo J, Lin HM, Duan Y, Pu M, Wolbrette DL, Liao D, J Intern Med 2007 262 1 113 122 10.1111/j.1365-2796. 2007.01781.x 17598819 (Pubitemid 47000624)
15. Metabolic syndrome and its association with morbidity and mortality. Ardern CI, Janssen I, Appl Physiol Nutr Metab 2007 32 1 33 45 10.1139/h06-099 17332783
16. Impact of body mass index and the metabolic syndrome on the risk of cardiovascular disease and death in middle-aged men. Arnlov J, Ingelsson E, Sundstrom J, Lind L, Circulation 121 2 230 236
17. The metabolic syndrome adds utility to the prediction of mortality over its components: The Vietnam Experience Study. Thomas GN, Phillips AC, Carroll D, Gale CR, Batty GD, Atherosclerosis 2009
18. Brachial-ankle pulse wave velocity as a marker of atherosclerotic vascular damage and cardiovascular risk. Yamashina A, Tomiyama H, Arai T, Hirose K, Koji Y, Hirayama Y, Yamamoto Y, Hori S, Hypertens Res 2003 26 8 615 622 10.1291/hypres.26.615 14567500 (Pubitemid 37080794)
19. Impact of the metabolic syndrome and its components on pulse wave velocity. Kim YK, Korean J Intern Med 2006 21 2 109 115 16913440
20. Brachial-ankle pulse wave velocity is useful for evaluation of complications in type 2 diabetic patients. Aso K, Miyata M, Kubo T, Hashiguchi H, Fukudome M, Fukushige E, Koriyama N, Nakazaki M, Minagoe S, Tei C, Hypertens Res 2003 26 10 807 813 10.1291/hypres.26.807 14621184 (Pubitemid 37406949)
21. Brachial-ankle pulse wave velocity measured automatically by oscillometric method is elevated in diabetic patients with incipient nephropathy. Yokoyama H, Hirasawa K, Aoki T, Ishiyama M, Koyama K, Diabet Med 2003 20 11 942 945 10.1046/j.1464-5491.2003.01043.x 14632721 (Pubitemid 41701495)
22. Circulating thrombomodulin levels are related to latent progression of atherosclerosis in hypertensive patients. Dohi Y, Ohashi M, Sugiyama M, Takase H, Sato K, Ueda R, Hypertens Res 2003 26 6 479 483 10.1291/hypres.26.479 12862205 (Pubitemid 36857067)
23. Elevated circulating endothelial microparticles and brachial-ankle pulse wave velocity in well-controlled hypertensive patients. Wang JM, Su C, Wang Y, Huang YJ, Yang Z, Chen L, Wu F, Xu SY, Tao J, J Hum Hypertens 2009 23 5 307 315 10.1038/jhh.2008.137 19037229
24. Prognostic significance of ankle-brachial index, brachial-ankle pulse wave velocity, flow-mediated dilation, and nitroglycerin-mediated dilation in end-stage renal disease. Morimoto S, Yurugi T, Aota Y, Sakuma T, Jo F, Nishikawa M, Iwasaka T, Maki K, Am J Nephrol 2009 30 1 55 63 10.1159/000201416 19204388
25. Comparison of ankle-brachial index and brachial-ankle pulse wave velocity between patients with chronic kidney disease and hemodialysis. Chen SC, Chang JM, Hwang SJ, Chen JH, Lin FH, Su HM, Chen HC, Am J Nephrol 2009 29 5 374 380 10.1159/000168485 18974638
26. Association of brachial-ankle pulse wave velocity with cardiovascular risk factors in systemic lupus erythematosus. Tso TK, Huang WN, Huang HY, Chang CK, Lupus 2005 14 11 878 883 10.1191/0961203305lu2234oa 16335579 (Pubitemid 41736368)
27. Metabolic syndrome is a significant and independent risk factor for increased arterial stiffness in Japanese subjects. Satoh H, Kishi R, Tsutsui H, Hypertens Res 2009 32 12 1067 1071 10.1038/hr.2009.158 19779485
28. Systemic assessment of arterial wall structure and function in metabolic syndrome. Kovaite M, Petrulioniene Z, Ryliskyte L, Badariene J, Dzenkeviciute V, Cypiene A, Laucevicius A, Polena S, Gintautas J, Proc West Pharmacol Soc 2007 50 123 130 18605248
29. Clinical impact of metabolic syndrome by modified NCEP-ATPIII criteria on carotid atherosclerosis in Japanese adults. Teramura M, Emoto M, Araki T, Yokoyama H, Motoyama K, Shinohara K, Mori K, Koyama H, Shoji T, Inaba M, et al. J Atheroscler Thromb 2007 14 4 172 178 10.5551/jat.E505 17704617
30. The association between pulse wave velocity and metabolic syndrome and adiponectin in patients with impaired fasting glucose: cardiovascular risks and adiponectin in IFG. Nam JS, Park JS, Cho MH, Jee SH, Lee HS, Ahn CW, Lowe WL, Kim KR, Diabetes Res Clin Pract 2009 84 2 145 151 10.1016/j.diabres.2009.02.002 19261346
31. Metabolic syndrome is associated with markers of subclinical atherosclerosis in a French population-based sample. Ahluwalia N, Drouet L, Ruidavets JB, Perret B, Amar J, Boccalon H, Hanaire-Broutin H, Ferrieres J, Atherosclerosis 2006 186 2 345 353 10.1016/j.atherosclerosis.2005.07.021 16129441
32. Metabolic syndrome is associated with increased arterial stiffness and biomarkers of subclinical atherosclerosis in patients with systemic lupus erythematosus. Sabio JM, Vargas-Hitos J, Zamora-Pasadas M, Mediavilla JD, Navarrete N, Ramirez A, Hidalgo-Tenorio C, Jaimez L, Martin J, Jimenez-Alonso J, J Rheumatol 2009 36 10 2204 2211 10.3899/jrheum.081253 19723903
33. Changes in brachial-ankle pulse wave velocity in subclinical hypothyroidism during normalization of thyroid function. Nagasaki T, Inaba M, Yamada S, Kumeda Y, Hiura Y, Nishizawa Y, Biomed Pharmacother 2007 61 8 482 487 10.1016/j.biopha.2007.04.004 17544610 (Pubitemid 47385088)
34. The effects of changes in the metabolic syndrome detection status on arterial stiffening: a prospective study. Tomiyama H, Hirayama Y, Hashimoto H, Yambe M, Yamada J, Koji Y, Motobe K, Shiina K, Yamamoto Y, Yamashinai A, Hypertens Res 2006 29 9 673 678 10.1291/hypres.29.673 17249522 (Pubitemid 44605365)
35. Metabolic syndrome and age-related progression of aortic stiffness. Safar ME, Thomas F, Blacher J, Nzietchueng R, Bureau JM, Pannier B, Benetos A, J Am Coll Cardiol 2006 47 1 72 75 10.1016/j.jacc.2005.08.052 16386667 (Pubitemid 43005167)
36. Limitations of the application of fourfold table analysis to hospital data. Berkson J, Biometrics 1946 2 3 47 53 10.2307/3002000 21001024
37. An analysis of Berkson's bias in case-control studies. Feinstein AR, Walter SD, Horwitz RI, J Chronic Dis 1986 39 7 495 504 10.1016/0021-9681(86) 90194-3 3722313 (Pubitemid 16070694)
38. Validity, reproducibility, and clinical significance of noninvasive brachial-ankle pulse wave velocity measurement. Yamashina A, Tomiyama H, Takeda K, Tsuda H, Arai T, Hirose K, Koji Y, Hori S, Yamamoto Y, Hypertens Res 2002 25 3 359 364 10.1291/hypres.25.359 12135313 (Pubitemid 34752554)
39. Childhood blood pressure as a predictor of arterial stiffness in young adults: the bogalusa heart study. Li S, Chen W, Srinivasan SR, Berenson GS, Hypertension 2004 43 3 541 546 10.1161/01.HYP.0000115922.98155.23 14744922 (Pubitemid 38282425)
40. Ventricular arterial stiffening: integrating the pathophysiology. Kass DA, Hypertension 2005 46 1 185 193 10.1161/01.HYP.0000168053.34306.d4 15911741 (Pubitemid 40946512)
41. Diabetes, advanced glycation endproducts and vascular disease. Wautier JL, Guillausseau PJ, Vasc Med 1998 3 2 131 137 9796076